Chapter 11 - RULES GOVERNING THE CONTROLLED SUBSTANCES PRESCRIPTION MONITORING PROGRAM AND PRESCRIPTION OF OPIOID MEDICATIONS

  1. § 118-11-1 - Introduction
  2. § 118-11-2 - Purpose
  3. § 118-11-3 - Definitions
  4. § 118-11-4 - General Requirements for Prescribing and Dispensing
  5. § 118-11-5 - Prescription Monitoring Program Requirements
  6. § 118-11-6 - Limits on Opioid Medications Prescribing and Exemptions to Limits
  7. § 118-11-7 - Access to Prescription Monitoring Information
  8. § 118-11-8 - Confidentiality
  9. § 118-11-9 - Review of Information
  10. § 118-11-10 - Penalties and Sanctions
  11. § 118-11-11 - Immunity from Liability
  12. § 118-11-12 - Audit

NOTICE: Although the Maine Legislature designated the PMP rule as a major substantive rule, 22 M.R.S. Sec.7252, the Maine Legislature in P.L. 2015, ch. 488 directed that some PMP rule provisions are routine technical rules. Accordingly, this rule contains both major substantive and routine technical provisions. The Routine Technical rule provisions are labeled accordingly in the left hand column, and also bolded, in order to differentiate them from the major substantive provisions.

Notes

EFFECTIVE DATE:
June 22, 2004 - filing 2004-225, EMERGENCY, effective for 90 days
June 26, 2005 - filing 2005-192
AMENDED:
June 9, 2010 - filing 2010-186 (Final adoption, major substantive)
September 18, 2011 - filing 2011-291 (Final adoption, major substantive)
July 11, 2015 - filing 2015-108 (Final adoption, major substantive)
9/16/2017- filing 2017- 126 (Routine technical and Final adoption, major substantive)

STATUTORY AUTHORITY: 22 MRSA Ch. 1603, Resolve 2005 ch. 36, 2017 Resolves, Ch. 16; P.L. 2017, ch. 213

State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.

No prior version found.